Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

Motesanib diphosphate (AMG-706)

Cat. No.: OB0225WX-2388
Appearance: Solid
Purity: ≥99%
Identity: Confirmed by NMR, and HPLC.
Size:
Motesanib diphosphate (AMG-706)
Add to basket

Product Overview

Description: Motesanib diphosphate is a potent, ATP-competitive inhibitor of VEGFR1, 2, and 3 (IC50: 2, 3, and 6 nM) with comparable activity against c-Kit and high selectivity over PDGFR.
Synonym: 857876-30-3; Motesanib diphosphate; AMG-706; Motesanib (Diphosphate); Motesanib Diphosphate (AMG-706); Motesanib phosphate; AMG 706 (Diphosphate); AMG706; 3-Pyridinecarboxamide, N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-((4-pyridinylmethyl)amino)-, phosphate (1:2); N-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide;phosphoric acid; MOTESANIB DIPHOSPHATE (MART.); N-(3,3-Dimethylindolin-6-yl)-2-((pyridin-4-ylmethyl)amino)nicotinamide diphosphate; N-(3,3-Dimethyl-2,3-dihydro-1H-indol-6-yl)-2-((pyridin-4-ylmethyl)amino)pyridine-3-carboxamide diphosphate; N-(3,3-Dimethyl-2,3-dihydro-1H-indol-6-yl)-2-[(pyridin-4-ylmethyl)amino]pyridine-3-carboxamide diphosphate; MFCD12407403; N-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide,phosphoric acid; N-(3,3-dimethylindolin-6-yl)-2-(pyridin-4-ylmethylamino)nicotinamide bis(phosphate); N-(3,3-Dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide diphosphate; N-(3,3-dimethyl-2,3-dihydro-1H-indol-6-yl)-2-((pyridin-4-ylmethyl)amino)pyridine-3-carboxamide phosphate (1:2)
CAS No.: 857876-30-3
Compound CID: 16097729
Formula: C22H23N5O·2H3PO4
Formula Weight: 569.44

Specification

Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: Motesanib diphosphate is used in oncological studies as a potent inhibitor of VEGF, PDGF, and Kit receptors to investigate the disruption of vascular development and the suppression of solid tumor xenografts.

Library Information

Target: c-Kit; PDGFR; VEGFR
Receptor: c-Kit; PDGFR; VEGFR
Pathways: Protein tyrosine kinase
Plate Number: L6700-01
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 10mM DMSO
DMSO Max Solubility: 100 mg/mL; 175.61 mM
Water Max Solubility: 19 mg/mL; 33.37 mM
ALogP: 1.783
HBA_Count: 3
HBD_Count: 3
Rotatable Bond: 5
Inquiry
0
Inquiry Basket

Copyright © Protheragen. All rights reserves.